StonvexLoading…
StonvexStonvexStonvexCore line items from NWBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $749.67M | $669.20M | $587.92M | $448.80M |
Operating Income | $162.79M | $129.55M | $175.08M | $173.69M |
Net Income | $126.01M | $100.28M | $134.96M | $133.67M |
EPS (Diluted) | $0.92 | $0.79 | $1.06 | $1.05 |
Total Assets | $16.77B | $14.41B | $14.42B | $14.11B |
Total Liabilities | $14.88B | $12.81B | $12.87B | $12.62B |
Cash & Equivalents | $233.65M | $288.38M | $122.26M | $139.37M |
Free Cash Flow OCF − CapEx | $141.78M | $125.36M | $84.33M | $171.11M |
Shares Outstanding | 146.11M | 127.51M | 127.11M | 127.03M |